Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    pr610
Show Display Options
Rank Status Study
1 Terminated A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Drug: PR610

Indicates status has not been verified in more than two years